Effect of various antibiotics on modulation of intestinal microbiota and bile acid profile in mice

Toxicology and Applied Pharmacology

Volumn 277, Issue 2, 2014, Pages 138-145

  Zhang, Youcai ^a   Limaye, Pallavi B ^a   Renaud, Helen J ^a   Klaassen, Curtis D ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotics; Bile acids; Enterohepatic circulation; Intestinal bacteria; Intestine; Liver

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BILE ACID; BILE SALT EXPORT PUMP; CEFALOTIN; CIPROFLOXACIN; CYTOCHROME P450; IMIPENEM; MESSENGER RNA; METRONIDAZOLE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; NEOMYCIN; SODIUM BILE ACID COTRANSPORTER; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1B2; VANCOMYCIN;

ANIMAL EXPERIMENT; ANTIBIOTIC THERAPY; ARTICLE; BACILLUS MYCOIDES; BACTERIAL METABOLISM; BACTEROIDES; BACTEROIDETES; BILE ACID BLOOD LEVEL; BILE ACID METABOLISM; BILE ACID SYNTHESIS; CLOSTRIDIUM; CLOSTRIDIUM CLOSTRIDIOFORME; COMMUNITY STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; ENTEROHEPATIC CIRCULATION; EUBACTERIUM; EUBACTERIUM LIMOSUM; FIRMICUTES; GENE EXPRESSION; HELICOBACTER; INTESTINE FLORA; KLEBSIELLA GRANULOMATIS; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS REUTERI; LACTOBACILLUS SALIVARIUS; LIVER LEVEL; MALE; MICROBIAL COMMUNITY; MOUSE; NONHUMAN; PARABACTEROIDES DISTASONIS; PORPHYROMONAS; RALSTONIA; RUMINOCOCCUS; SIGNAL TRANSDUCTION; TANNERELLA FORSYTHENSIS;

ANTIBIOTICS; BILE ACIDS; ENTEROHEPATIC CIRCULATION; INTESTINAL BACTERIA; INTESTINE; LIVER;

ANIMALS; ANTI-BACTERIAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIA; BILE ACIDS AND SALTS; DRUG THERAPY, COMBINATION; ENTEROHEPATIC CIRCULATION; GENE EXPRESSION REGULATION; INTESTINES; LIVER; MALE; MICE; MICE, INBRED C57BL; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; RNA, MESSENGER; STEROID 12-ALPHA-HYDROXYLASE; SYMPORTERS;

EID: 84899145858     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2014.03.009     Document Type: Article

References (33)

1. Antunes L.C., Han J., Ferreira R.B., Lolic P., Borchers C.H., Finlay B.B. Effect of antibiotic treatment on the intestinal metabolome. Antimicrob. Agents Chemother. 2011, 55:1494-1503.
2. Bayerdorffer E., Mannes G.A., Ochsenkuhn T., Dirschedl P., Wiebecke B., Paumgartner G. Unconjugated secondary bile acids in the serum of patients with colorectal adenomas. Gut 1995, 36:268-273.
3. Benedetti A., Alvaro D., Bassotti C., Gigliozzi A., Ferretti G., La Rosa T., Di Sario A., Baiocchi L., Jezequel A.M. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver. Hepatology 1997, 26:9-21.
4. Botham K.M., Boyd G.S. The metabolism of chenodeoxycholic acid to beta-muricholic acid in rat liver. Eur. J. Biochem. 1983, 134:191-196.
5. Changbumrung S., Tungtrongchitr R., Migasena P., Chamroenngan S. Serum unconjugated primary and secondary bile acids in patients with cholangiocarcinoma and hepatocellular carcinoma. J. Med. Assoc. Thai. 1990, 73:81-90.
6. Chaplin M.F. Bile acids, fibre and colon cancer: the story unfolds. J. R. Soc. Health 1998, 118:53-61.
7. Davies Y.K., Cox K.M., Abdullah B.A., Safta A., Terry A.B., Cox K.L. Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic. J. Pediatr. Gastroenterol. Nutr. 2008, 47:61-67.
8. Goodwin B., Jones S.A., Price R.R., Watson M.A., McKee D.D., Moore L.B., Galardi C., Wilson J.G., Lewis M.C., Roth M.E., Maloney P.R., Willson T.M., Kliewer S.A. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 2000, 6:517-526.
9. Goris H., de Boer F., van der Waaij D. Oral administration of antibiotics and intestinal flora associated endotoxin in mice. Scand. J. Infect. Dis. 1986, 18:55-63.
10. Hofmann A.F., Hagey L.R. Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell. Mol. Life Sci. 2008, 65:2461-2483.
11. Hoentjen F., Harmsen H.J.M., Braat H., Torrice C.D., Mann B.A., Sartor R.B., Dieleman L.A. Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice. Gut. 2003, 52:1721-1727.
12. Kawamata Y., Fujii R., Hosoya M., Harada M., Yoshida H., Miwa M., Fukusumi S., Habata Y., Itoh T., Shintani Y., Hinuma S., Fujisawa Y., Fujino M. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 2003, 278:9435-9440.
13. Kim I., Ahn S.H., Inagaki T., Choi M., Ito S., Guo G.L., Kliewer S.A., Gonzalez F.J. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J. Lipid Res. 2007, 48:2664-2672.
14. Kong B., Wang L., Chiang J.Y., Zhang Y., Klaassen C.D., Guo G.L. Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology 2012, 56:1034-1043.
15. Kuribayashi H., Miyata M., Yamakawa H., Yoshinari K., Yamazoe Y. Enterobacteria-mediated deconjugation of taurocholic acid enhances ileal farnesoid X receptor signaling. Eur. J. Pharmacol. 2012, 697:132-138.
16. Ley R.E., Hamady M., Lozupone C., Turnbaugh P.J., Ramey R.R., Bircher J.S., Schlegel M.L., Tucker T.A., Schrenzel M.D., Knight R., Gordon J.I. Evolution of mammals and their gut microbes. Science 2008, 320:1647-1651.
17. Makishima M., Okamoto A.Y., Repa J.J., Tu H., Learned R.M., Luk A., Hull M.V., Lustig K.D., Mangelsdorf D.J., Shan B. Identification of a nuclear receptor for bile acids. Science 1999, 284:1362-1365.
18. Parks D.J., Blanchard S.G., Bledsoe R.K., Chandra G., Consler T.G., Kliewer S.A., Stimmel J.B., Willson T.M., Zavacki A.M., Moore D.D., Lehmann J.M. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999, 284:1365-1368.
19. Ridlon J.M., Hylemon P.B. Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7alpha-dehydroxylating intestinal bacterium. J. Lipid Res. 2011, 53:66-76.
20. Ridlon J.M., Kang D.J., Hylemon P.B. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 2006, 47:241-259.
21. Russell D.W. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 2003, 72:137-174.
22. Salzman N.H., de Jong H., Paterson Y., Harmsen H.J., Welling G.W., Bos N.A. Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology 2002, 148:3651-3660.
23. Sato H., Macchiarulo A., Thomas C., Gioiello A., Une M., Hofmann A.F., Saladin R., Schoonjans K., Pellicciari R., Auwerx J. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J. Med. Chem. 2008, 51:1831-1841.
24. Sayin S.I., Wahlstrom A., Felin J., Jantti S., Marschall H.U., Bamberg K., Angelin B., Hyotylainen T., Oresic M., Backhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013, 17:225-235.
25. Sinakos E., Marschall H.U., Kowdley K.V., Befeler A., Keach J., Lindor K. Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: relation to disease progression. Hepatology 2010, 52:197-203.
26. Song P., Zhang Y., Klaassen C.D. Dose-response of five bile acids on serum and liver bile acid concentrations and hepatotoxicty in mice. Toxicol. Sci. 2011, 123:359-367.
27. Swann J.R., Want E.J., Geier F.M., Spagou K., Wilson I.D., Sidaway J.E., Nicholson J.K., Holmes E. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc. Natl. Acad. Sci. U. S. A. 2010, 108(Suppl. 1):4523-4530.
28. Takamine F., Imamura T. 7 beta-dehydroxylation of 3,7-dihydroxy bile acids by a Eubacterium species strain C-25 and stimulation of 7 beta-dehydroxylation by Bacteroides distasonis strain K-5. Microbiol. Immunol. 1985, 29:1247-1252.
29. Wang H., Chen J., Hollister K., Sowers L.C., Forman B.M. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell 1999, 3:543-553.
30. Zhang Y., Klaassen C.D. Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice. J. Lipid Res. 2010, 51:3230-3242.
31. Zhang Y., Hong J.Y., Rockwell C.E., Copple B.L., Jaeschke H., Klaassen C.D. Effect of bile duct ligation on bile acid composition in mouse serum and liver. Liver Int. 2011, 32:58-69.
32. Zhang Y., Csanaky I.L., Cheng X., Lehman-McKeeman L.D., Klaassen C.D. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury. Toxicol. Sci. 2012, 127:451-462.
33. Zhang Y., Limaye P.B., Lehman-McKeeman L.D., Klaassen C.D. Dysfunction of organic anion transporting polypeptide 1a1 alters intestinal bacteria and bile acid metabolism in mice. PLoS One 2012, 7:e34522.